Your browser doesn't support javascript.
loading
An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model.
Hedges, Jodi F; Snyder, Deann T; Robison, Amanda; Grifka-Walk, Heather M; Blackwell, Karlin; Shepardson, Kelly; Kominsky, Douglas; Rynda-Apple, Agnieszka; Walcheck, Bruce; Jutila, Mark A.
Afiliação
  • Hedges JF; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Snyder DT; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Robison A; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Grifka-Walk HM; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Blackwell K; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Shepardson K; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Kominsky D; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Rynda-Apple A; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
  • Walcheck B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States.
  • Jutila MA; Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, United States.
Front Immunol ; 13: 918881, 2022.
Article em En | MEDLINE | ID: mdl-35757773

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Proteína ADAM17 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Proteína ADAM17 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça